uracil has been researched along with Dermatitis, Contact in 5 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Dermatitis, Contact: A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although topical corticosteroids have been widely utilized in steroid-responsive dermatoses such as AD, their chronic use may be associated with significant side effects." | 1.32 | Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses. ( Hayashi, H; Inoue, Y; Isobe, M; Shiohara, T, 2003) |
| "The T-cell-mediated contact hypersensitivity reaction (CHR) is thought to be involved in the pathogenesis of clinical cutaneous disorders including atopic dermatitis." | 1.31 | Suppressive effect of topically applied CX-659S, a novel diaminouracil derivative, on the contact hypersensitivity reaction in various animal models. ( Furue, M; Goto, Y; Hayashi, H; Inoue, Y; Isobe, M; Tsuchiya, M; Uchi, H; Ueno, T, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isobe, Y | 1 |
| Tobe, M | 1 |
| Takahashi, O | 1 |
| Goto, Y | 2 |
| Inoue, Y | 4 |
| Obara, F | 1 |
| Tsuchiya, M | 2 |
| Hayashi, H | 4 |
| Isobe, M | 3 |
| Shiohara, T | 1 |
| Kawakubo, Y | 1 |
| Nakamori, M | 1 |
| Schöpf, E | 1 |
| Ohkido, M | 1 |
| Ueno, T | 1 |
| Uchi, H | 1 |
| Furue, M | 1 |
5 other studies available for uracil and Dermatitis, Contact
| Article | Year |
|---|---|
Synthesis and activity of a metabolite of (S)-6-amino-5-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)-3-methyl-1-phenyl-2,4-(1H,3H)-pyrimidinedione (CX-659S).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Contact; Dogs; Male; Mice; Mice, Inbre | 2002 |
The combined effect of topical CX-659S, a novel diaminouracil derivative, with topical corticosteroid on the three types of allergic responses in mice or guinea pigs.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; | 2003 |
Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chronic Disease; Dermatitis, Atopic; Der | 2003 |
Acetylator phenotype in patients with p-phenylenediamine allergy.
Topics: Acetylation; Biomarkers; Caffeine; Chromatography, High Pressure Liquid; Coloring Agents; Dermatitis | 1997 |
Suppressive effect of topically applied CX-659S, a novel diaminouracil derivative, on the contact hypersensitivity reaction in various animal models.
Topics: Administration, Topical; Animals; Base Sequence; Dermatitis, Contact; Dinitrochlorobenzene; Disease | 2000 |